Deferasirox
NDC 69539-074, Deferasirox, tablet, from MSN LABORATORIES PRIVATE LIMITED.
- Product NDC
- 69539-074
- Status
- Listed
- Labeler
- MSN LABORATORIES PRIVATE LIMITED
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210945
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69539-074 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEFERASIROX180 mg/1
Pharmacologic classes
Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69539-074-30 | 69539007430 | 30 TABLET in 1 BOTTLE (69539-074-30) |
| 69539-074-99 | 69539007499 | 1000 TABLET in 1 BOTTLE (69539-074-99) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0354cbc7-9b32-4513-976a-2ef2da39b6b3
Use it
Look up 69539-074 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69539-074 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69539-074. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.